CD19 expression is maintained in DLBCL patients after treatment with tafasitamab plus lenalidomide in the L-MIND study

Duell, J; Obr, A; Augustin, M; Endell, J; Liu, H; Geiger, S; Silverman, IM; Ambarkhane, S; Rosenwald, A

Duell, J (通讯作者)，Univ Klin Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany.

LEUKEMIA & LYMPHOMA, 2022; 63 (2): 468

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索